NIH/DOD 2013 Non-Dilutive Funding Forecast

Monday, March 18 2013
8:30 am – 11:00 am

Location: Boston Marriot Cambridge, Two Cambridge Center, 50 Broadway Cambridge, MA 02142

FreeMind Group, working with MassBio, is pleased to invite you to a presentation on non-dilutive sources funding for the Life science industry, with an emphasis on a 2013 funding forecast. 

 Click here to register   - THIS EVENT IS FREE OF CHARGE - 

8:30am - 9:00am 

Light breakfast and networking  

9:00am - 10:00am

Presentation  - 2013 Non-Dilutive Funding Forecast 

Presenter:

Ram May-Ron, Managing Partner, FreeMind Group

10:00am - 12:00pm

Meet the expert - 1x1 meetings with FreeMind's Managing Partner Ram May-Ron

 Click here to register  - THIS EVENT IS FREE OF CHARGE -   

We are witnessing a continuous movement by the NIH and DOD towards the life science industry, with a greater understanding as to the industry's needs, focus, and challenges. The scope of funding support given to industry R&D efforts from non-dilutive sources such as NIH and DOD covers the entire R&D cycle from early stage exploratory activities and all the way to late stage clinical research activities (Phase I, and II).

All non-dilutive sources are now expressing greater than ever interest in the R&D efforts of the industry, and more so in the unique set of skills and assets presented by collaborative academia-industry alliances. In the presentation we will discuss the latest trends at the NIH and DOD and the new available large scale and clinical stage funding opportunities.    

In addition we will discuss:

  • Large scale funding opportunities
  • The challenges in putting together a complex and large scale application
  • 2013 Funding forecast 
  • Process for applying, requirements and limitations
  • How to maximize chances for success
  • Industry & academia collaboration
  • Government funding as a strategic source of funding

To register FREE of charge, or to schedule a 1x1 meeting with Ram May-Ron please click here to register.   

 

 

More Information

Carla Klein

FreeMind Group

carla@freemindconsultants.com

617 648 0340 x249

 

Share MassBio

 

EvaluatePharma

MassBio